World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat
Authors
Keywords
<em class=EmphasisTypeItalic >H. pylori</em>, Gastric cancer, Clarithromycin, Metronidazole, Fluoroquinolone
Journal
JOURNAL OF GASTROENTEROLOGY
Volume 53, Issue 3, Pages 354-361
Publisher
Springer Nature
Online
2017-11-14
DOI
10.1007/s00535-017-1407-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect on Helicobacter pylori eradication therapy against gastric cancer in Japan
- (2017) Momoko Tsuda et al. HELICOBACTER
- Effects of patient age and choice of antisecretory agent on success of eradication therapy for Helicobacter pylori infection
- (2017) Toshihiro Nishizawa et al. JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION
- Acquisition of double mutation in gyrA caused high resistance to sitafloxacin in Helicobacter pylori after unsuccessful eradication with sitafloxacin-containing regimens
- (2017) Hideki Mori et al. United European Gastroenterology Journal
- Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy forHelicobacter pylorieradication: a phase III, randomised, double-blind study
- (2016) Kazunari Murakami et al. GUT
- Management ofHelicobacter pyloriinfection—the Maastricht V/Florence Consensus Report
- (2016) P Malfertheiner et al. GUT
- Rifabutin Containing Triple Therapy and Rifabutin with Bismuth Containing Quadruple Therapy for Third-Line Treatment ofHelicobacter pyloriInfection: Two Pilot Studies
- (2016) Antonio Francesco Ciccaglione et al. HELICOBACTER
- Rescue therapy with bismuth-containing quadruple therapy in patients infected with metronidazole-resistant Helicobacter pylori strains
- (2016) Nelly Muller et al. Clinics and Research in Hepatology and Gastroenterology
- Antimicrobial susceptibility profiles of Helicobacter pylori isolated from patients in North India
- (2016) Valentina Gehlot et al. Journal of Global Antimicrobial Resistance
- Kyoto global consensus report onHelicobacter pylorigastritis
- (2015) Kentaro Sugano et al. GUT
- Efficacy of 10-day Sitafloxacin-Containing Third-Line Rescue Therapies forHelicobacter pyloriStrains Containing thegyrAMutation
- (2015) Hideki Mori et al. HELICOBACTER
- Time Trends inHelicobacter pyloriInfection and Atrophic Gastritis Over 40 Years in Japan
- (2015) Tomoari Kamada et al. HELICOBACTER
- Helicobacter pylori gastritis—a novel distinct disease entity
- (2015) Hidekazu Suzuki et al. Nature Reviews Gastroenterology & Hepatology
- Antimicrobial resistance of Helicobacter pylori strains to five antibiotics, including levofloxacin, in Northwestern Turkey
- (2015) Reyhan Caliskan et al. Revista da Sociedade Brasileira de Medicina Tropical
- Low efficacy of levofloxacin-doxycycline-based third-line triple therapy forHelicobacter pylorieradication in Italy
- (2015) Omero Alessandro Paoluzi WORLD JOURNAL OF GASTROENTEROLOGY
- Primary antibiotic resistance ofHelicobacter pyloristrains isolated from patients with dyspeptic symptoms in Beijing: A prospective serial study
- (2015) Yue-Xi Zhang WORLD JOURNAL OF GASTROENTEROLOGY
- Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study
- (2015) Hideki Mori et al. United European Gastroenterology Journal
- Helicobacter pylori CagA and Gastric Cancer: A Paradigm for Hit-and-Run Carcinogenesis
- (2014) Masanori Hatakeyama Cell Host & Microbe
- Management ofHelicobacter pylori-Related Diseases in the Baltic States
- (2014) Juozas Kupcinskas et al. DIGESTIVE DISEASES
- Prevalence of lesions detected at upper endoscopy: An Italian survey
- (2014) Angelo Zullo et al. European Journal of Internal Medicine
- Rifabutin-based High-dose Proton-pump Inhibitor and Amoxicillin Triple Regimen as the Rescue treatment forHelicobacter pylori
- (2014) Hyun Chul Lim et al. HELICOBACTER
- Effect ofHelicobacter pyloriEradication on Metachronous Gastric Cancer after Endoscopic Resection of Gastric Tumors: A Meta-Analysis
- (2014) Seung Bae Yoon et al. HELICOBACTER
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Changes in the first lineHelicobacter pylorieradication rates using the triple therapy-a multicenter study in the Tokyo metropolitan area (TokyoHelicobacter pyloristudy group)
- (2014) Takashi Kawai et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Optimizing clarithromycin-containing therapy forHelicobacter pyloriin the era of antibiotic resistance
- (2014) Javier Molina-Infante WORLD JOURNAL OF GASTROENTEROLOGY
- Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials
- (2014) A. C. Ford et al. BMJ-British Medical Journal
- Trends of Second-Line Eradication Therapy forHelicobacter pyloriin Japan: A Multicenter Study in the Tokyo Metropolitan Area
- (2013) Daisuke Asaoka et al. HELICOBACTER
- Multi-center randomized controlled study to establish the standard third-line regimen for Helicobacter pylori eradication in Japan
- (2013) Kazunari Murakami et al. JOURNAL OF GASTROENTEROLOGY
- Antibiotic Resistance inHelicobacter pyloriStrains and its Effect onH. pyloriEradication Rates in a Single Center in Korea
- (2013) Byoungrak An et al. Annals of Laboratory Medicine
- Fourth-line rescue therapy with rifabutin in patients with three Helicobacter pylori eradication failures
- (2012) J. P. Gisbert et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Nonbismuth Quadruple (Concomitant) Therapy: Empirical and Tailored Efficacy versus Standard Triple Therapy for Clarithromycin-Susceptible Helicobacter pylori and versus Sequential Therapy for Clarithromycin-Resistant Strains
- (2012) Javier Molina-Infante et al. HELICOBACTER
- The Incidence of Primary Antibiotic Resistance of Helicobacter pylori in Vietnam
- (2012) Tran T. Binh et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Dual therapy for third-lineHelicobacter pylorieradication and urea breath test prediction
- (2012) Toshihiro Nishizawa WORLD JOURNAL OF GASTROENTEROLOGY
- Review article: rifabutin in the treatment of refractory Helicobacter pylori infection
- (2011) J. P. Gisbert et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Helicobacter pylori Resistance to Rifabutin in the Last 7 Years
- (2011) Toshihiro Nishizawa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Enhancement of Amoxicillin Resistance after Unsuccessful Helicobacter pylori Eradication
- (2011) Toshihiro Nishizawa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy of Sitafloxacin-Based Rescue Therapy for Helicobacter pylori after Failures of First- and Second-Line Therapies
- (2011) Juntaro Matsuzaki et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Genotypic Resistance inHelicobacter pyloriStrains Correlates with Susceptibility Test and Treatment Outcomes after Levofloxacin- and Clarithromycin-Based Therapies
- (2010) Jyh-Ming Liou et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Incidence of chronic atrophic gastritis: systematic review and meta-analysis of follow-up studies
- (2010) Mariam Abdullahi Adamu et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Helicobacter pylorieradication therapy
- (2010) Hidekazu Suzuki et al. Future Microbiology
- The long-term risk of gastric cancer after the successful eradication of Helicobacter pylori
- (2010) Susumu Take et al. JOURNAL OF GASTROENTEROLOGY
- Homology model of the DNA gyrase enzyme of Helicobacter pylori, a target of quinolone-based eradication therapy
- (2010) Juntaro Matsuzaki et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Sitafloxacin and Garenoxacin May Overcome the Antibiotic Resistance of Helicobacter pylori with gyrA Mutation
- (2009) H. Suzuki et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Past Rifampicin Dosing Determines Rifabutin Resistance of Helicobacter pylori
- (2009) Shoji Suzuki et al. DIGESTION
- Quinolone-Based Third-Line Therapy for Helicobacter pylori Eradication
- (2009) Toshihiro Nishizawa et al. JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION
- Resistance to metronidazole, clarithromycin and levofloxacin ofHelicobacter pyloribefore and after clarithromycin-based therapy in Taiwan
- (2009) Wei-Lun Chang et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Prevalence and evolution of Helicobacter pylori resistance to 6 antibacterial agents over 12 years and correlation between susceptibility testing methods
- (2008) Lyudmila Boyanova et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial
- (2008) Kazutoshi Fukase et al. LANCET
- “Rescue” regimens after Helicobacter pylori treatment failure
- (2008) Javier P Gisbert WORLD JOURNAL OF GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search